Moreover, biologics targeting to Ang1-TIE2 pathway may be applied to the high fatality rate of the latest global crisis, COVID-19 infection and its comorbidities, involving acute respiratory distress syndrome, cardiovascular diseases, obesity and diabetes [102,103,104,105,106]. This evidence concerns the gene ANGPT1 and acute respiratory distress syndrome.